Clinical trial

Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children

NCT03375775

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-05-01

PhaseNA

Study timeline

Study start (actual)2017-05-01Date precision: day

Registry last updated2022-04-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rhinitis, Allergicunresolved

Conjunctivitis, Allergicunresolved

Asthmaunresolved

Interventions

Subcutaneous immunotherapy with ALK Alutard birch or ALK Alutard timothyDRUG

No immunotherapy, symptomatic treatmentOTHER

Sponsors & collaborators

Karolinska Institutetlead sponsor

Mapped research locations

StockholmSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03375775 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.